1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,112 | 1,144 | 16:36 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.11. | Invitation to Nanoform's Q3 2024 Report Presentation | 2 | Cision News | ||
| 25.10. | Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release | 2 | Cision News | ||
| 22.10. | Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 | 1 | Cision News | ||
| 05.09. | Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants | 5 | Cision News | ||
| 29.08. | Nanoform Q2 report: All business targets for 2024 on track | 1 | Cision News | ||
| 16.08. | Invitation to Nanoform's Q2 2024 Report Presentation | 1 | Cision News | ||
| NANOFORM FINLAND Aktie jetzt für 0€ handeln | |||||
| 15.08. | Nanoform Collaborates with Takeda on Plasma-derived Therapy Development | 14 | Contract Pharma | ||
| 15.08. | NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT | 773 | PR Newswire | HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development... ► Artikel lesen | |
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Miguel Calado | 1 | Cision News | ||
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Albert Hæggström | 3 | Cision News | ||
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Mads Laustsen | 1 | Cision News | ||
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Jeanne Thoma | 1 | Cision News | ||
| 14.06. | Share subscriptions based on the resolution by Nanoform Finland Plc's Annual General Meeting 2024 on remuneration of the Board of Directors | 1 | Cision News | ||
| 30.05. | Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned | 508 | PR Newswire | HELSINKI, May 30, 2024 /PRNewswire/ -- Manufacturing of GMP material in Project Nanoenzalutamide commenced. EU/US pivotal studies are planned to start in 4Q24, with the read-out in 1Q25.... ► Artikel lesen | |
| 29.05. | NANOFORM: Disclosure of Major Holdings under Law 163/2024 | 1 | Cision News | ||
| 09.04. | Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer | 748 | PR Newswire | Nanoform Finland Plc
April 9, 2024
09.00 EEST / 08.00 CEST
HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company... ► Artikel lesen | |
| 15.02. | Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines | 623 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
| 26.01. | Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide | 685 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
| 05.01. | Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide | 892 | PR Newswire | HELSINKI, Jan. 5, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV)... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 46,350 | -0,96 % | Formycon Aktie: Optimismus nimmt zu! | Die Formycon AG verzeichnet im Zuge ihres Börsengangs am 11. November 2024 signifikante Veränderungen in der Aktionärsstruktur. Mehrere Großaktionäre haben ihre Beteiligungen offengelegt, was die Aufmerksamkeit... ► Artikel lesen | |
| ONTO INNOVATION | 150,00 | -0,66 % | Onto Innovation Reports 2024 Third Quarter Results | WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation Inc. (NYSE: ONTO) ("Onto Innovation," "Onto," or the "Company") today announced financial results for the third fiscal quarter of 2024.
Third... ► Artikel lesen | |
| VEECO INSTRUMENTS | 25,400 | +0,79 % | Veeco stock touches 52-week low at $27.33 amid market shifts | ||
| KOPIN | 0,823 | +3,33 % | Kopin Corp Q3 Loss Increases, But Beats Estimates | WASHINGTON (dpa-AFX) - Kopin Corp (KOPN) reported Loss for its third quarter that increased from last year but beat the Street estimates.The company's earnings came in at -$3.46 million, or... ► Artikel lesen | |
| NANOVIRICIDES | 1,180 | +0,85 % | NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID | SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September... ► Artikel lesen | |
| GAUZY | 7,570 | -2,45 % | Gauzy shares rise as Q3 loss narrows, revenue growth strong | ||
| ACACIA RESEARCH | 4,040 | +1,00 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| NVE | 70,50 | -2,08 % | Dividendenbekanntmachungen (04.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIANCEBERNSTEIN HOLDING LP US01881G1067 0,77 USD 0,7107 EUR AMCON DISTRIBUTING COMPANY US02341Q2057 0,18 USD 0,1661 EUR AMERIPRISE... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,428 | -0,47 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LEHNER INVESTMENTS | 0,015 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
| NANOFOCUS | 1,470 | 0,00 % | NanoFocus passt Prognose für 2024 an | Die NanoFocus AG hat heute beschlossen, die Prognose für das laufende Jahr anzupassen. Aufgrund von gegenwärtig absehbar deutlich niedrigeren Umsätzen in den Bereichen Semiconductor Asia und Standard/Labor... ► Artikel lesen | |
| RIBER | 2,530 | +0,40 % | RIBER: Solid Business Growth at End-September 2024 | SOLID BUSINESS GROWTH AT END-SEPTEMBER 2024 Revenues up +14% to €18.5mOrder book strengthened to €38.3m (+14%) Bezons, October 30, 2024 - 8:00am - RIBER, the global leader for molecular beam epitaxy... ► Artikel lesen | |
| GOMSPACE | 0,321 | 0,00 % | GOMSPACE A/S: ESA and GomSpace sign 8.4 MSEK contract change notice for the GOMX-5 project | ||
| XTPL | 22,450 | 0,00 % | EQS-News: XTPL S.A.: XTPL expects 2025 to be a record-breaking year, the new DPS+ business line is to support implementation of its strategic goal | Issuer: XTPL S.A.
/ Key word(s): Quarter Results/Quarterly / Interim Statement
XTPL expects 2025 to be a record-breaking year, the new DPS+ business line is to support implementation... ► Artikel lesen | |
| INSPLORION | 0,029 | -10,06 % | Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of Insplorion AB | At the request of Insplorion AB, the last trading day in Insplorion AB's paid
subscription units will be changed from 2024-11-13 to 2024-11-18.
Instrument: Paid subscription units
Short... ► Artikel lesen |
Das Unternehmen NANOFORM FINLAND OYJ kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,87 % bei einem Aktienkurs von 1,136 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOFORM FINLAND OYJ finden Sie auf Wallstreet Online.
